$CCRD
CoreCard Corp

2020 Q2 Form 10-Q Financial Statement

#000143774920016378 Filed on August 04, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2
Revenue $8.053M $7.512M
YoY Change 7.2% 64.27%
Cost Of Revenue $3.694M $2.899M
YoY Change 27.42% 41.97%
Gross Profit $4.359M $4.613M
YoY Change -5.51% 82.26%
Gross Profit Margin 54.13% 61.41%
Selling, General & Admin $735.0K $1.151M
YoY Change -36.14% 127.92%
% of Gross Profit 16.86% 24.95%
Research & Development $921.0K $861.0K
YoY Change 6.97% 21.44%
% of Gross Profit 21.13% 18.66%
Depreciation & Amortization $390.0K $250.0K
YoY Change 56.0% 108.33%
% of Gross Profit 8.95% 5.42%
Operating Expenses $1.656M $2.012M
YoY Change -17.69% 65.73%
Operating Profit $2.703M $2.601M
YoY Change 3.92% 97.49%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $117.0K $146.0K
YoY Change -19.86% -177.25%
Pretax Income $2.725M $2.726M
YoY Change -0.04% 141.67%
Income Tax $525.0K $618.0K
% Of Pretax Income 19.27% 22.67%
Net Earnings $2.200M $2.108M
YoY Change 4.36% 99.24%
Net Earnings / Revenue 27.32% 28.06%
Basic Earnings Per Share $0.25 $0.24
Diluted Earnings Per Share $0.24 $0.23
COMMON SHARES
Basic Shares Outstanding 8.925M 8.851M
Diluted Shares Outstanding 9.019M 9.005M

Balance Sheet

Concept 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $32.32M $22.24M
YoY Change 45.32% 101.08%
Cash & Equivalents $32.32M $21.88M
Short-Term Investments $370.0K
Other Short-Term Assets $1.058M $690.0K
YoY Change 53.33% -86.19%
Inventory
Prepaid Expenses
Receivables $8.136M $4.123M
Other Receivables $1.060M $0.00
Total Short-Term Assets $42.57M $27.06M
YoY Change 57.36% 35.15%
LONG-TERM ASSETS
Property, Plant & Equipment $4.253M $2.606M
YoY Change 63.2% 71.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $2.160M $3.410M
YoY Change -36.66% 348.68%
Other Assets $3.497M $1.585M
YoY Change 120.63% 498.11%
Total Long-Term Assets $11.45M $8.857M
YoY Change 29.25% 106.75%
TOTAL ASSETS
Total Short-Term Assets $42.57M $27.06M
Total Long-Term Assets $11.45M $8.857M
Total Assets $54.02M $35.91M
YoY Change 50.43% 47.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $431.0K $434.0K
YoY Change -0.69% 59.56%
Accrued Expenses $238.0K $105.0K
YoY Change 126.67% 32.91%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $10.81M $5.022M
YoY Change 115.29% 82.35%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.320M $690.0K
YoY Change 236.23% 762.5%
Total Long-Term Liabilities $2.596M $686.0K
YoY Change 278.43% 757.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.81M $5.022M
Total Long-Term Liabilities $2.596M $686.0K
Total Liabilities $13.41M $5.708M
YoY Change 134.9% 100.99%
SHAREHOLDERS EQUITY
Retained Earnings $25.09M $15.06M
YoY Change 66.66% 128.73%
Common Stock $15.66M $15.28M
YoY Change 2.52% 1.68%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $40.61M $30.20M
YoY Change
Total Liabilities & Shareholders Equity $54.02M $35.91M
YoY Change 50.43% 47.77%

Cashflow Statement

Concept 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income $2.200M $2.108M
YoY Change 4.36% 99.24%
Depreciation, Depletion And Amortization $390.0K $250.0K
YoY Change 56.0% 108.33%
Cash From Operating Activities $4.020M $2.240M
YoY Change 79.46% 82.11%
INVESTING ACTIVITIES
Capital Expenditures $2.230M $1.410M
YoY Change 58.16% 302.86%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$1.000M
YoY Change -100.0% 112.77%
Cash From Investing Activities -$2.230M -$2.410M
YoY Change -7.47% 193.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities 4.020M 2.240M
Cash From Investing Activities -2.230M -2.410M
Cash From Financing Activities 0.000 0.000
Net Change In Cash 1.790M -170.0K
YoY Change -1152.94% -138.64%
FREE CASH FLOW
Cash From Operating Activities $4.020M $2.240M
Capital Expenditures $2.230M $1.410M
Free Cash Flow $1.790M $830.0K
YoY Change 115.66% -5.68%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Document Type
DocumentType
10-Q
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8924988
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value for the class
ins Increase Decrease In Deferred Revenue Current
IncreaseDecreaseInDeferredRevenueCurrent
4112000
ins Increase Decrease In Deferred Revenue Current
IncreaseDecreaseInDeferredRevenueCurrent
33000
ins Increase Decrease In Deferred Revenue Noncurrent
IncreaseDecreaseInDeferredRevenueNoncurrent
-14000
ins Increase Decrease In Deferred Revenue Noncurrent
IncreaseDecreaseInDeferredRevenueNoncurrent
-51000
ins Noncash Interest Income
NoncashInterestIncome
55000
ins Noncash Interest Income
NoncashInterestIncome
18000
CY2020Q2 ins Notes And Interest Receivable Current
NotesAndInterestReceivableCurrent
1063000
CY2019Q4 ins Notes And Interest Receivable Current
NotesAndInterestReceivableCurrent
CY2020Q2 ins Notes And Interest Receivable Noncurrent
NotesAndInterestReceivableNoncurrent
1543000
CY2019Q4 ins Notes And Interest Receivable Noncurrent
NotesAndInterestReceivableNoncurrent
1795000
CY2020Q2 ins Number Of Stockbased Compensation Plans In Effect
NumberOfStockbasedCompensationPlansInEffect
3
ins Payments For Notes And Interest Receivable
PaymentsForNotesAndInterestReceivable
1000000
ins Payments For Notes And Interest Receivable
PaymentsForNotesAndInterestReceivable
1500000
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
431000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
403000
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8136000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8759000
CY2020Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1965000
CY2019Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1100000
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
238000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
153000
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-140000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-94000
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
15573000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
15450000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
25000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
55000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
62000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
61000
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
61000
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
55000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
123000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
80000
CY2020Q2 us-gaap Assets
Assets
54021000
CY2019Q4 us-gaap Assets
Assets
44240000
CY2020Q2 us-gaap Assets Current
AssetsCurrent
42573000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
36079000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32316000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26415000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26415000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
18919000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
32316000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
21875000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5901000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2956000
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8924988
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8924988
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8924988
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8924988
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
89000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
89000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2185000
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2073000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3201000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4144000
CY2020Q2 us-gaap Cost Of Revenue
CostOfRevenue
3694000
CY2019Q2 us-gaap Cost Of Revenue
CostOfRevenue
2899000
us-gaap Cost Of Revenue
CostOfRevenue
7201000
us-gaap Cost Of Revenue
CostOfRevenue
5433000
us-gaap Costmethod Investments Other Than Temporary Impairment
CostmethodInvestmentsOtherThanTemporaryImpairment
1009000
us-gaap Costmethod Investments Other Than Temporary Impairment
CostmethodInvestmentsOtherThanTemporaryImpairment
CY2020Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
275000
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
275000
CY2020Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
4801000
CY2019Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
689000
CY2020Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
9000
CY2019Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
23000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
691000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
428000
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.23
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.36
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.46
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-46000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-36000
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1649000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2503000
CY2020Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
292000
CY2020Q1 us-gaap Equity Method Investments
EquityMethodInvestments
0
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
704000
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1100000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1762000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1694000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2725000
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2726000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4190000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5456000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-176000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
525000
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
618000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
943000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1276000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
250000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
28000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
162000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-623000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
392000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
85000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
34000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-854000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
27000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
153000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-432000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
705000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
1010000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
9000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-29000
CY2020Q2 us-gaap Investment Income Net
InvestmentIncomeNet
-95000
CY2019Q2 us-gaap Investment Income Net
InvestmentIncomeNet
-21000
us-gaap Investment Income Net
InvestmentIncomeNet
-1145000
us-gaap Investment Income Net
InvestmentIncomeNet
4000
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
54021000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
44240000
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
10812000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6193000
CY2020Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2596000
CY2019Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
758000
CY2020Q2 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
CY2019Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
CY2020Q2 us-gaap Long Term Investments
LongTermInvestments
2155000
CY2019Q4 us-gaap Long Term Investments
LongTermInvestments
3081000
CY2020Q2 us-gaap Marketing Expense
MarketingExpense
31000
CY2019Q2 us-gaap Marketing Expense
MarketingExpense
51000
us-gaap Marketing Expense
MarketingExpense
63000
us-gaap Marketing Expense
MarketingExpense
89000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
59000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3767000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3021000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
9714000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5954000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
2200000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
2108000
us-gaap Net Income Loss
NetIncomeLoss
3247000
us-gaap Net Income Loss
NetIncomeLoss
4180000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
2072000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
1047000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2059000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
2703000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
2601000
us-gaap Operating Income Loss
OperatingIncomeLoss
5082000
us-gaap Operating Income Loss
OperatingIncomeLoss
5203000
CY2020Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
291000
CY2019Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
142000
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2312000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
460000
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.039
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.055
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y292D
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y36D
CY2020Q2 us-gaap Other Assets Current
OtherAssetsCurrent
1058000
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
905000
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3497000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1108000
CY2019Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1000
CY2019Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-35000
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-31000
CY2020Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-15000
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-15000
CY2019Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-35000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-46000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-36000
CY2020Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1728000
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1345000
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
117000
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
146000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
253000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
249000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2767000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1521000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
59000
CY2020Q2 us-gaap Profit Loss
ProfitLoss
2200000
CY2019Q2 us-gaap Profit Loss
ProfitLoss
2108000
us-gaap Profit Loss
ProfitLoss
3247000
us-gaap Profit Loss
ProfitLoss
4180000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4253000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2177000
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
921000
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
861000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1838000
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
25091000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
21844000
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
8053000
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
7512000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
15946000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
14478000
us-gaap Share Based Compensation
ShareBasedCompensation
123000
us-gaap Share Based Compensation
ShareBasedCompensation
80000
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3220540
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
126500
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.94
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
2938740
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
102500
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
5.61
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y109D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P3Y36D
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
59000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
25921000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
28076000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
30204000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
37289000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
38367000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
40613000
CY2020Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2019Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9019025
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9004664
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9020470
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9015669
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8924988
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8850988
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8924988
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8846155

Files In Submission

Name View Source Status
0001437749-20-016378-index-headers.html Edgar Link pending
0001437749-20-016378-index.html Edgar Link pending
0001437749-20-016378.txt Edgar Link pending
0001437749-20-016378-xbrl.zip Edgar Link pending
ex_194929.htm Edgar Link pending
ex_194931.htm Edgar Link pending
ex_194932.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
ins-20200630.xml Edgar Link completed
ins-20200630.xsd Edgar Link pending
ins-20200630_cal.xml Edgar Link unprocessable
ins-20200630_def.xml Edgar Link unprocessable
ins-20200630_lab.xml Edgar Link unprocessable
ins-20200630_pre.xml Edgar Link unprocessable
ins20200601_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending